Cinclus Pharma Holding AB (publ) (STO:CINPHA)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Clinical Stage Drug for Gastric Acid Related Diseases	5.96M
Clinical Stage Drug for Gastric Acid Related Diseases Growth	-43.63%

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
China	5.96M
China Growth	-43.63%